EasyTechnical

99 practiced

A stakeholder presents a bar chart where the y-axis starts at 90% and a small change looks visually huge. Explain why truncating axes and other visualization choices can mislead business users. Provide at least three concrete changes you would make to that visualization (and to the dashboard design) to improve accurate interpretation while keeping the chart actionable for executives.

HardTechnical

71 practiced

You observe that frequent product usage correlates with retention but cannot run a randomized experiment. Design an observational study to estimate the causal effect of increased usage on retention. Describe required data, the identification assumptions you would need, candidate methods (propensity score matching, inverse-probability weighting, difference-in-differences, instrumental variables), balance diagnostics, and sensitivity analyses for unobserved confounding. Explain how you would communicate strengths and limitations of the result to stakeholders.

Sample Answer

Approach: treat this as an observational causal-estimation problem. Goal: estimate the average causal effect of increasing product usage (treatment) on retention (outcome) using historical data and quasi-experimental methods, then quantify robustness.

Required data:- User-level panel: timestamps of sessions/events, retention indicator (e.g., 30/90-day), user covariates (demographics, signup date, acquisition source, initial activity), product-state variables (plan, features used), prior engagement history (baseline usage before treatment window).- Time-varying covariates and outcomes across multiple pre/post periods to enable DiD or longitudinal adjustments.- Potential instruments (e.g., A/B of non-random notifications or rollout timing) if available.- Large sample and sufficient overlap across usage levels.

Identification assumptions (explicit):- No unmeasured confounding given observed covariates (conditional ignorability) for matching/IPW.- Positivity/overlap: every user has non-zero probability of being in each usage level given covariates.- For DiD: parallel trends in retention between high- and low-usage groups absent treatment.- For IV: instrument is correlated with usage (relevance), affects retention only via usage (exclusion), and is as-good-as-random (independence), plus monotonicity if LATE interpretation.

Candidate methods:1. Propensity score matching (PSM) - Estimate propensity to be high-usage (logistic/GBM) using rich covariates and past behavior. - Match (1:1 or caliper) or use nearest-neighbor with replacement.2. Inverse-probability weighting (IPW) - Stabilized weights from propensity scores to create pseudo-population; then weighted regression for average treatment effect.3. Difference-in-differences (DiD) - If usage change occurs at identifiable time, compare retention trends pre/post vs control; include user fixed effects and time trends.4. Instrumental variables (IV) - Use natural instrument (e.g., staged feature rollout, assignment to onboarding coach) and two-stage least squares to estimate local average treatment effect.5. Longitudinal G-methods - Marginal structural models if time-varying confounding affected by prior usage.

Diagnostics and balance:- Check covariate balance before/after adjustment: standardized mean differences (SMD) with threshold |SMD| < 0.1; show Love plots.- For IPW: examine weight distribution, truncated extreme weights, effective sample size.- For DiD: test pre-trends via event-study coefficients; plot parallel trend visualization.- For IV: test instrument strength (F-stat > 10), overidentification tests if multiple instruments.- Outcome falsification: test effect on placebo outcomes that should not be affected by usage.

Sensitivity analyses for unobserved confounding:- Rosenbaum bounds to quantify how strong an unobserved confounder must be to change conclusions.- E-value to report minimum confounding strength (risk ratio scale) required to explain away effect.- Include negative-control exposures/outcomes.- Alternate model specifications: add additional controls, nonlinear models, trimming, and bootstrap CIs.- If DiD: fit synthetic control or augment with covariate-adjusted DiD.

Implementation notes:- Pre-register analysis plan (choices of covariates, calipers, windows).- Use robust/clustered SEs at user or cohort level.- Report ATT and ATE where identifiable; for IV, clearly label LATE and its population.

Communicating strengths & limitations to stakeholders:- Present point estimate with confidence intervals and sensitivity metrics (Rosenbaum bound, E-value).- Strengths: uses rich observational data, multiple complementary methods, robustness checks reduce but don’t eliminate bias.- Limitations: residual confounding possible; PSM/IPW relies on observed covariates, IV requires strong instrument assumptions, DiD requires parallel trends. Be explicit which assumptions are most plausible given product context (e.g., rollout timing plausibly exogenous).- Recommendation: if results robust, pilot intervention (encouragement design like nudges) to create randomized evidence; otherwise treat as directional evidence when prioritizing experiments.

Expected deliverables: analysis notebook, balance plots (Love plot), event-study graphs, sensitivity tables (E-value/Rosenbaum), and a one-page summary with actionable recommendations and uncertainty bounds.

HardTechnical

56 practiced

You attribute a lift in average order value to a new pricing strategy. Draft a comprehensive robustness and sensitivity analysis plan that tests alternative explanations such as concurrent marketing campaigns, product mix shifts, customer-cohort changes, seasonal effects, and data-processing bugs. Include placebo/falsification tests, alternative model specifications, and how you would quantify residual uncertainty.

Sample Answer

Framework / goal: determine whether the observed lift in Average Order Value (AOV) is causally attributable to the new pricing strategy vs. alternative explanations (marketing, product mix, cohorts, seasonality, data bugs). I'll follow a hierarchy: data QA → descriptive decomposition → causal models with controls + falsification/placebo tests → sensitivity analysis → communicate residual uncertainty.

1) Data QA (first 48h)- Reconcile sources (orders, catalog, promo logs, marketing spend, user profiles). Check for duplicate/phantom orders, timezone shifts, ETL changes around launch.- Recompute AOV from raw transactions; compare to pipeline numbers; run diff-in-deltas pre/post by order id counts.

2) Descriptive decomposition- Break AOV = (Total Revenue)/(#Orders) into price, quantity per order, product mix (category-level shares), discount/coupon usage, and shipping fees. Visualize by day/week and by cohort (first-time vs. returning).- Plot marketing activities (spend, channel, campaign IDs) and product launches on same timeline.

3) Causal identification & primary models- Interrupted Time Series (ITS) with seasonal terms and AR errors: AOV_t = α + β*Post_t + f(seasonality) + AR terms + ε_t. β is main estimate.- Difference-in-Differences (DiD): if a control group exists (region/segment not exposed), run DiD controlling for time trends, fixed effects.- Synthetic Control: construct weighted combination of unaffected segments for robustness.- Regression with rich controls: product-mix shares, campaign indicators, daily marketing spend by channel, cohort composition, macro trends.

4) Placebo / falsification tests- Temporal placebo: run "fake" treatment dates before the true launch — estimate β; significant effects before treatment suggest confounding.- Outcome falsification: test outcomes that should not change (e.g., returns rate for old SKU, or site visits) — significant change undermines causal claim.- Segment placebo: run treatment on segments unlikely affected (e.g., VPN users or small-test region).

5) Alternative specifications- Vary model forms: include/exclude campaign controls, use log(AOV), use median order value, use customer-level panel with user fixed effects.- Use matching (propensity score matching on pre-period behavior) and re-estimate ATT.- Allow for heterogeneous effects by segment and run subgroup analyses.

6) Sensitivity analyses / quantifying residual uncertainty- Bootstrap CI on primary estimates and report percentile CIs.- Rosenbaum bounds / E-value to quantify how strong an unobserved confounder would need to be to explain away effect.- Bayesian model averaging over specifications to get posterior distribution of effect size; report 90% credible interval.- Variance decomposition: percentage of AOV change explained by price change vs. mix vs. marketing vs. cohort shifts.

7) Practical checks for data-processing bugs- Re-run using independent extraction (SQL vs. BI tool), sample-level audits, check for rounding/aggregation changes, verify time-alignment of promo flags.- Confirm transformation code with unit tests and row-count checks.

8) Reporting & decision rule- Present: point estimates with bootstrap/CIs, E-value, results of placebo tests (p-values), decomposition chart (how much of lift explained by each channel).- Decision thresholds: if >70% of lift robust to specifications and E-value indicates implausible confounder required, recommend attribution to pricing; otherwise recommend further controlled experiment (A/B or rollout) and label attribution as tentative.

This plan balances statistical rigor, operational checks, and clear metrics for communicating remaining uncertainty.

EasyBehavioral

66 practiced

You delivered a dashboard that shows a sudden jump in conversion rate this month. A stakeholder immediately assumes a new feature caused the change. Draft the specific caveats, uncertainty statements, and quick diagnostic checks you would add to the dashboard and how you would explain alternative explanations during a 5-minute meeting so stakeholders understand what the data can and cannot prove.

Sample Answer

Situation: I released a conversion-rate dashboard and stakeholders saw a large month-over-month jump; one immediately attributed it to a recently shipped feature.

Task: My job was to surface appropriate caveats on the dashboard, run quick diagnostics, and explain—clearly and briefly—what the data can and cannot prove so stakeholders avoid premature conclusions.

Action:- Dashboard caveats / uncertainty statements (visible near the metric): - "Caution: This is an observational metric. A change here does not imply causation." - "Data completeness: [last ingestion time]. Includes events from channels A, B; excludes channel C until 2025-11-30." - "Confidence: ±X% margin of sampling error (see method tab)." - "Potential confounders: traffic mix, promo campaigns, tracking changes."- Quick diagnostic checks (1–10 minutes each, linked from dashboard): - Compare cohorted conversion by UTM/source and device to detect traffic shifts. - Check funnel steps upstream/downstream for where lift occurred. - Inspect raw event volume for sudden spikes/drops (could indicate instrumentation issues). - Verify release and experiment logs: feature rollout percentage, A/B test status. - Validate data pipeline: schema changes, duplicate events, or new filters.- 5-minute meeting script (concise, factual): - Opening (30s): "We see a conversion uptick. That’s real in the dataset, but we should be careful about attributing cause." - Show diagnostics (2 min): highlight source/device cohorts, funnel step where lift concentrated, and that there’s no concurrent full rollout of the feature (or if there is, show rollout %). - Present plausible alternative explanations (90s): "Traffic composition changed (e.g., paid campaign), tracking or dedup changes, seasonal/competitive effects, or measurement bugs. Any of these could produce a similar jump." - Next steps (60s): "I’ll run a short causal checklist: verify instrumentation, run segmented pre-post comparisons with control cohorts, and if rollout included an experiment, fetch experiment assignment data for treatment/control comparison. Expect initial results in 24–48 hours." - Close: "Bottom line: promising signal worth investigating; current data cannot prove causality without further checks."

Result/Learning: This approach calmed assumptions, focused the team on targeted diagnostics, and prevented incorrect product attribution while we completed causal checks.

EasyTechnical

78 practiced

Before performing any analysis on a transactional dataset, explain why checking data provenance and metadata is critical. List the minimum metadata fields you would require for each row of a transactions table (for example: source system, ingestion timestamp, event timestamp, unique transaction id, user identifier, collection method) and explain two ways missing or incorrect metadata could change interpretation or create biases.

Critical Thinking About Data Limitations Questions

Sample Answer

Sample Answer

Sample Answer

Sample Answer

Sample Answer

Unlock Full Question Bank